Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 415

1.

In Reply to Slovak et al.

Jackson WC, Cuneo KC, Lawrence TS, Owen D.

Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):696-697. doi: 10.1016/j.ijrobp.2019.03.006. No abstract available.

PMID:
31162061
2.

Xenograft-based platform-independent gene signatures to predict response to alkylating chemotherapy, radiation, and combination therapy for glioblastoma.

Zhao SG, Yu M, Spratt DE, Chang SL, Feng FY, Kim MM, Speers CW, Carlson BL, Mladek AC, Lawrence TS, Sarkaria JN, Wahl DR.

Neuro Oncol. 2019 May 23. pii: noz090. doi: 10.1093/neuonc/noz090. [Epub ahead of print]

PMID:
31121035
3.

Inhibition of ATM increases interferon signaling and sensitizes pancreatic cancer to immune checkpoint blockade therapy.

Zhang Q, Green MD, Lang X, Lazarus J, Parsels J, Wei S, Parsels LA, Shi J, Ramnath N, Wahl DR, Pasca di Magliano M, Frankel TL, Kryczek I, Lei Y, Lawrence TS, Zou W, Morgan MA.

Cancer Res. 2019 May 17. pii: canres.0761.2019. doi: 10.1158/0008-5472.CAN-19-0761. [Epub ahead of print]

PMID:
31101760
4.

Serum Levels of Hepatocyte Growth Factor and CD40 Ligand Predict Radiation-Induced Liver Injury.

Cuneo KC, Devasia T, Sun Y, Schipper MJ, Karnak D, Davis MA, Owen D, Feng M, El Naqa I, Bazzi L, Ten Haken R, Lawrence TS.

Transl Oncol. 2019 Jul;12(7):889-894. doi: 10.1016/j.tranon.2019.04.003. Epub 2019 May 9.

5.

CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy.

Wang W, Green M, Choi JE, Gijón M, Kennedy PD, Johnson JK, Liao P, Lang X, Kryczek I, Sell A, Xia H, Zhou J, Li G, Li J, Li W, Wei S, Vatan L, Zhang H, Szeliga W, Gu W, Liu R, Lawrence TS, Lamb C, Tanno Y, Cieslik M, Stone E, Georgiou G, Chan TA, Chinnaiyan A, Zou W.

Nature. 2019 May;569(7755):270-274. doi: 10.1038/s41586-019-1170-y. Epub 2019 May 1.

PMID:
31043744
6.

Dose-intensified chemoradiation is associated with altered patterns of failure and favorable survival in patients with newly diagnosed glioblastoma.

Kim MM, Speers C, Li P, Schipper M, Junck L, Leung D, Orringer D, Heth J, Umemura Y, Spratt DE, Wahl DR, Cao Y, Lawrence TS, Tsien CI.

J Neurooncol. 2019 Jun;143(2):313-319. doi: 10.1007/s11060-019-03166-3. Epub 2019 Apr 11.

PMID:
30977058
7.

Circulating microRNAs as biomarkers of radiation-induced cardiac toxicity in non-small-cell lung cancer.

Hawkins PG, Sun Y, Dess RT, Jackson WC, Sun G, Bi N, Tewari M, Hayman JA, Kalemkerian GP, Gadgeel SM, Lawrence TS, Haken RKT, Matuszak MM, Kong FS, Schipper MJ, Jolly S.

J Cancer Res Clin Oncol. 2019 Jun;145(6):1635-1643. doi: 10.1007/s00432-019-02903-5. Epub 2019 Mar 28.

PMID:
30923943
8.

Developing a Pipeline for Multiparametric MRI-Guided Radiation Therapy: Initial Results from a Phase II Clinical Trial in Newly Diagnosed Glioblastoma.

Kim MM, Parmar HA, Aryal MP, Mayo CS, Balter JM, Lawrence TS, Cao Y.

Tomography. 2019 Mar;5(1):118-126. doi: 10.18383/j.tom.2018.00035.

9.

Association of Adjuvant Radiotherapy With Survival After Margin-negative Resection of Pancreatic Ductal Adenocarcinoma: A Propensity-matched National Cancer Database (NCDB) Analysis.

Kamarajah SK, Sonnenday CJ, Cho CS, Frankel TL, Bednar F, Lawrence TS, Nathan H.

Ann Surg. 2019 Feb 25. doi: 10.1097/SLA.0000000000003242. [Epub ahead of print]

PMID:
30817352
10.

The WD40 domain of FBXW7 is a poly(ADP-ribose)-binding domain that mediates the early DNA damage response.

Zhang Q, Mady ASA, Ma Y, Ryan C, Lawrence TS, Nikolovska-Coleska Z, Sun Y, Morgan MA.

Nucleic Acids Res. 2019 Feb 5. doi: 10.1093/nar/gkz058. [Epub ahead of print]

11.

PD-L1 Expression in Circulating Tumor Cells Increases during Radio(chemo)therapy and Indicates Poor Prognosis in Non-small Cell Lung Cancer.

Wang Y, Kim TH, Fouladdel S, Zhang Z, Soni P, Qin A, Zhao L, Azizi E, Lawrence TS, Ramnath N, Cuneo KC, Nagrath S.

Sci Rep. 2019 Jan 24;9(1):566. doi: 10.1038/s41598-018-36096-7.

12.

Clinical Development of Novel Drug-Radiotherapy Combinations.

Ahmad SS, Crittenden MR, Tran PT, Kluetz PG, Blumenthal GM, Bulbeck H, Baird RD, Williams KJ, Illidge T, Hahn SM, Lawrence TS, Spears PA, Walker AJ, Sharma RA.

Clin Cancer Res. 2019 Mar 1;25(5):1455-1461. doi: 10.1158/1078-0432.CCR-18-2466. Epub 2018 Nov 29.

PMID:
30498095
13.

Enhancing the Radiation Response in KRAS Mutant Colorectal Cancers Using the c-Met Inhibitor Crizotinib.

Cuneo KC, Mehta RK, Kurapati H, Thomas DG, Lawrence TS, Nyati MK.

Transl Oncol. 2019 Feb;12(2):209-216. doi: 10.1016/j.tranon.2018.10.005. Epub 2018 Nov 6.

14.

Greater reduction in mid-treatment FDG-PET volume may be associated with worse survival in non-small cell lung cancer.

Kong FS, Li L, Wang W, Campbell J, Waller JL, Piert M, Gross M, Cheng M, Owen D, Stenmark M, Huang KC, Frey KA, Ten Haken RK, Lawrence TS.

Radiother Oncol. 2019 Mar;132:241-249. doi: 10.1016/j.radonc.2018.10.006. Epub 2018 Oct 30.

PMID:
30389239
15.

Treatment data and technical process challenges for practical big data efforts in radiation oncology.

Mayo CS, Phillips M, McNutt TR, Palta J, Dekker A, Miller RC, Xiao Y, Moran JM, Matuszak MM, Gabriel P, Ayan AS, Prisciandaro J, Thor M, Dixit N, Popple R, Killoran J, Kaleba E, Kantor M, Ruan D, Kapoor R, Kessler ML, Lawrence TS.

Med Phys. 2018 Oct;45(10):e793-e810. doi: 10.1002/mp.13114. Epub 2018 Sep 18.

PMID:
30226286
16.

Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-Up.

Mendiratta-Lala M, Masch W, Shankar PR, Hartman HE, Davenport MS, Schipper MJ, Maurino C, Cuneo KC, Lawrence TS, Owen D.

Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):169-179. doi: 10.1016/j.ijrobp.2018.09.004. Epub 2018 Sep 10.

PMID:
30213751
17.

No Sugar Added: A New Strategy to Inhibit Glioblastoma Receptor Tyrosine Kinases.

Wahl DR, Lawrence TS.

Clin Cancer Res. 2019 Jan 15;25(2):455-456. doi: 10.1158/1078-0432.CCR-18-2113. Epub 2018 Sep 4.

PMID:
30181388
18.

Combining Perfusion and High B-value Diffusion MRI to Inform Prognosis and Predict Failure Patterns in Glioblastoma.

Wahl DR, Kim MM, Aryal MP, Hartman H, Lawrence TS, Schipper MJ, Parmar HA, Cao Y.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):757-764. doi: 10.1016/j.ijrobp.2018.04.045. Epub 2018 Jun 2.

PMID:
29980414
19.

Casual Causality: Does Radiofrequency Ablation Really Prolong Survival After Treatment of Localized Hepatocellular Carcinoma?

Wahl DR, Schipper MJ, Parikh ND, Owen D, Lawrence TS.

J Clin Oncol. 2018 Aug 20;36(24):2559-2560. doi: 10.1200/JCO.2018.78.0882. Epub 2018 Jun 26. No abstract available.

PMID:
29945526
20.

Chaperone Activity and Dimerization Properties of Hsp90α and Hsp90β in Glucocorticoid Receptor Activation by the Multiprotein Hsp90/Hsp70-Dependent Chaperone Machinery.

Morishima Y, Mehta RK, Yoshimura M, Lau M, Southworth DR, Lawrence TS, Pratt WB, Nyati MK, Osawa Y.

Mol Pharmacol. 2018 Sep;94(3):984-991. doi: 10.1124/mol.118.112516. Epub 2018 Jun 25.

PMID:
29941666
21.

The contribution of DNA replication stress marked by high-intensity, pan-nuclear γH2AX staining to chemosensitization by CHK1 and WEE1 inhibitors.

Parsels LA, Parsels JD, Tanska DM, Maybaum J, Lawrence TS, Morgan MA.

Cell Cycle. 2018;17(9):1076-1086. doi: 10.1080/15384101.2018.1475827. Epub 2018 Jul 18.

PMID:
29895190
22.

Effectiveness and cost of radiofrequency ablation and stereotactic body radiotherapy for treatment of early-stage hepatocellular carcinoma: An analysis of SEER-medicare.

Parikh ND, Marshall VD, Green M, Lawrence TS, Razumilava N, Owen D, Singal AG, Feng M.

J Med Imaging Radiat Oncol. 2018 Oct;62(5):673-681. doi: 10.1111/1754-9485.12754. Epub 2018 Jun 7.

PMID:
29877615
23.

A multiobjective Bayesian networks approach for joint prediction of tumor local control and radiation pneumonitis in nonsmall-cell lung cancer (NSCLC) for response-adapted radiotherapy.

Luo Y, McShan DL, Matuszak MM, Ray D, Lawrence TS, Jolly S, Kong FM, Ten Haken RK, El Naqa I.

Med Phys. 2018 Jun 4. doi: 10.1002/mp.13029. [Epub ahead of print]

PMID:
29862533
24.

Quantification of liver function by linearization of a two-compartment model of gadoxetic acid uptake using dynamic contrast-enhanced magnetic resonance imaging.

Simeth J, Johansson A, Owen D, Cuneo K, Mierzwa M, Feng M, Lawrence TS, Cao Y.

NMR Biomed. 2018 Jun;31(6):e3913. doi: 10.1002/nbm.3913. Epub 2018 Apr 19.

25.

Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression.

Lin H, Wei S, Hurt EM, Green MD, Zhao L, Vatan L, Szeliga W, Herbst R, Harms PW, Fecher LA, Vats P, Chinnaiyan AM, Lao CD, Lawrence TS, Wicha M, Hamanishi J, Mandai M, Kryczek I, Zou W.

J Clin Invest. 2018 Apr 2;128(4):1708. doi: 10.1172/JCI120803. Epub 2018 Apr 2. No abstract available.

26.

Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases.

Jackson WC, Tao Y, Mendiratta-Lala M, Bazzi L, Wahl DR, Schipper MJ, Feng M, Cuneo KC, Lawrence TS, Owen D.

Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):950-958. doi: 10.1016/j.ijrobp.2017.12.014. Epub 2017 Dec 15.

27.

Standard dose and dose-escalated radiation therapy are associated with favorable survival in select elderly patients with newly diagnosed glioblastoma.

Jackson WC, Tsien CI, Junck L, Leung D, Hervey-Jumper S, Orringer D, Heth J, Wahl DR, Spratt DE, Cao Y, Lawrence TS, Kim MM.

J Neurooncol. 2018 May;138(1):155-162. doi: 10.1007/s11060-018-2782-z. Epub 2018 Feb 1.

PMID:
29388034
28.

Modeling of Normal Tissue Complications Using Imaging and Biomarkers After Radiation Therapy for Hepatocellular Carcinoma.

El Naqa I, Johansson A, Owen D, Cuneo K, Cao Y, Matuszak M, Bazzi L, Lawrence TS, Ten Haken RK.

Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):335-343. doi: 10.1016/j.ijrobp.2017.10.005.

29.

Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression.

Lin H, Wei S, Hurt EM, Green MD, Zhao L, Vatan L, Szeliga W, Herbst R, Harms PW, Fecher LA, Vats P, Chinnaiyan AM, Lao CD, Lawrence TS, Wicha M, Hamanishi J, Mandai M, Kryczek I, Zou W.

J Clin Invest. 2018 Feb 1;128(2):805-815. doi: 10.1172/JCI96113. Epub 2018 Jan 16. Erratum in: J Clin Invest. 2018 Apr 2;128(4):1708.

30.

Prognostic Value of c-MET Expression in Patients With Pancreatic Cancer Receiving Adjuvant and Neoadjuvant Chemoradiation Therapy.

Cuneo KC, Morgan MA, Griffith KA, Hawkins PG, Greenson JK, Ben-Josef E, Lawrence TS, Zalupski MM.

Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):490-497. doi: 10.1016/j.ijrobp.2017.10.030. Epub 2017 Oct 28.

31.

Prediction of Radiation Esophagitis in Non-Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine Levels.

Hawkins PG, Boonstra PS, Hobson ST, Hayman JA, Ten Haken RK, Matuszak MM, Stanton P, Kalemkerian GP, Lawrence TS, Schipper MJ, Kong FS, Jolly S.

Transl Oncol. 2018 Feb;11(1):102-108. doi: 10.1016/j.tranon.2017.11.005. Epub 2017 Dec 18.

32.

Ensuring sample quality for blood biomarker studies in clinical trials: a multicenter international study for plasma and serum sample preparation.

Kong FS, Zhao L, Wang L, Chen Y, Hu J, Fu X, Bai C, Wang L, Lawrence TS, Anscher MS, Dicker A, Okunieff P.

Transl Lung Cancer Res. 2017 Dec;6(6):625-634. doi: 10.21037/tlcr.2017.09.13.

33.

Tumor image signatures and habitats: a processing pipeline of multimodality metabolic and physiological images.

You D, Kim MM, Aryal MP, Parmar H, Piert M, Lawrence TS, Cao Y.

J Med Imaging (Bellingham). 2018 Jan;5(1):011009. doi: 10.1117/1.JMI.5.1.011009. Epub 2017 Nov 15.

34.

PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP Inhibitors.

Parsels LA, Karnak D, Parsels JD, Zhang Q, Vélez-Padilla J, Reichert ZR, Wahl DR, Maybaum J, O'Connor MJ, Lawrence TS, Morgan MA.

Mol Cancer Res. 2018 Feb;16(2):222-232. doi: 10.1158/1541-7786.MCR-17-0455. Epub 2017 Nov 13.

35.

Using Indocyanine Green Extraction to Predict Liver Function After Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.

Suresh K, Owen D, Bazzi L, Jackson W, Ten Haken RK, Cuneo K, Feng M, Lawrence TS, Schipper MJ.

Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):131-137. doi: 10.1016/j.ijrobp.2017.09.032. Epub 2017 Sep 22.

36.

Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma.

Sapir E, Tao Y, Schipper MJ, Bazzi L, Novelli PM, Devlin P, Owen D, Cuneo KC, Lawrence TS, Parikh ND, Feng M.

Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):122-130. doi: 10.1016/j.ijrobp.2017.09.001. Epub 2017 Sep 14.

37.

Serum MicroRNA Signature Predicts Response to High-Dose Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer.

Sun Y, Hawkins PG, Bi N, Dess RT, Tewari M, Hearn JWD, Hayman JA, Kalemkerian GP, Lawrence TS, Ten Haken RK, Matuszak MM, Kong FM, Jolly S, Schipper MJ.

Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):107-114. doi: 10.1016/j.ijrobp.2017.08.039. Epub 2017 Sep 4.

38.

Imaging Findings Within the First 12 Months of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy.

Mendiratta-Lala M, Gu E, Owen D, Cuneo KC, Bazzi L, Lawrence TS, Hussain HK, Davenport MS.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1063-1069. doi: 10.1016/j.ijrobp.2017.08.022. Epub 2017 Aug 24.

PMID:
29029891
39.

Radiation-induced lung toxicity in non-small-cell lung cancer: Understanding the interactions of clinical factors and cytokines with the dose-toxicity relationship.

Hawkins PG, Boonstra PS, Hobson ST, Hearn JWD, Hayman JA, Ten Haken RK, Matuszak MM, Stanton P, Kalemkerian GP, Ramnath N, Lawrence TS, Schipper MJ, Spring Kong FM, Jolly S.

Radiother Oncol. 2017 Oct;125(1):66-72. doi: 10.1016/j.radonc.2017.09.005. Epub 2017 Sep 23.

40.

Implementing Radiation Dose-Volume Liver Response in Biomechanical Deformable Image Registration.

Polan DF, Feng M, Lawrence TS, Ten Haken RK, Brock KK.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):1004-1012. doi: 10.1016/j.ijrobp.2017.06.2455. Epub 2017 Jun 27.

41.

Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer.

Speers C, Zhao SG, Chandler B, Liu M, Wilder-Romans K, Olsen E, Nyati S, Ritter C, Alluri PG, Kothari V, Hayes DF, Lawrence TS, Spratt DE, Wahl DR, Pierce LJ, Feng FY.

NPJ Breast Cancer. 2017 Aug 18;3:29. doi: 10.1038/s41523-017-0038-2. eCollection 2017.

42.

Blood-tumor barrier opening changes in brain metastases from pre to one-month post radiation therapy.

Teng F, Tsien CI, Lawrence TS, Cao Y.

Radiother Oncol. 2017 Oct;125(1):89-93. doi: 10.1016/j.radonc.2017.08.006. Epub 2017 Aug 20.

PMID:
28835339
43.

Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial.

Feng M, Suresh K, Schipper MJ, Bazzi L, Ben-Josef E, Matuszak MM, Parikh ND, Welling TH, Normolle D, Ten Haken RK, Lawrence TS.

JAMA Oncol. 2018 Jan 1;4(1):40-47. doi: 10.1001/jamaoncol.2017.2303.

44.

The big data effort in radiation oncology: Data mining or data farming?

Mayo CS, Kessler ML, Eisbruch A, Weyburne G, Feng M, Hayman JA, Jolly S, El Naqa I, Moran JM, Matuszak MM, Anderson CJ, Holevinski LP, McShan DL, Merkel SM, Machnak SL, Lawrence TS, Ten Haken RK.

Adv Radiat Oncol. 2016 Oct 13;1(4):260-271. doi: 10.1016/j.adro.2016.10.001. eCollection 2016 Oct-Dec. Review.

45.

Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer: A Phase 2 Clinical Trial.

Kong FM, Ten Haken RK, Schipper M, Frey KA, Hayman J, Gross M, Ramnath N, Hassan KA, Matuszak M, Ritter T, Bi N, Wang W, Orringer M, Cease KB, Lawrence TS, Kalemkerian GP.

JAMA Oncol. 2017 Oct 1;3(10):1358-1365. doi: 10.1001/jamaoncol.2017.0982.

46.

Involvement of p38-βTrCP-Tristetraprolin-TNFα axis in radiation pneumonitis.

Krishnamurthy PM, Shukla S, Ray P, Mehra R, Nyati MK, Lawrence TS, Ray D.

Oncotarget. 2017 Jul 18;8(29):47767-47779. doi: 10.18632/oncotarget.17770.

47.

Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung Cancer.

Dess RT, Sun Y, Matuszak MM, Sun G, Soni PD, Bazzi L, Murthy VL, Hearn JWD, Kong FM, Kalemkerian GP, Hayman JA, Ten Haken RK, Lawrence TS, Schipper MJ, Jolly S.

J Clin Oncol. 2017 May 1;35(13):1395-1402. doi: 10.1200/JCO.2016.71.6142. Epub 2017 Mar 16.

48.

Genomic-adjusted radiation dose.

Spratt DE, Wahl DR, Lawrence TS.

Lancet Oncol. 2017 Mar;18(3):e127. doi: 10.1016/S1470-2045(17)30092-X. Epub 2017 Mar 2. No abstract available.

PMID:
28271860
49.

Quantitative Proteomic Analysis of Serum Exosomes from Patients with Locally Advanced Pancreatic Cancer Undergoing Chemoradiotherapy.

An M, Lohse I, Tan Z, Zhu J, Wu J, Kurapati H, Morgan MA, Lawrence TS, Cuneo KC, Lubman DM.

J Proteome Res. 2017 Apr 7;16(4):1763-1772. doi: 10.1021/acs.jproteome.7b00024. Epub 2017 Mar 8.

50.

Unraveling biophysical interactions of radiation pneumonitis in non-small-cell lung cancer via Bayesian network analysis.

Luo Y, El Naqa I, McShan DL, Ray D, Lohse I, Matuszak MM, Owen D, Jolly S, Lawrence TS, Kong FS, Ten Haken RK.

Radiother Oncol. 2017 Apr;123(1):85-92. doi: 10.1016/j.radonc.2017.02.004. Epub 2017 Feb 22.

Supplemental Content

Loading ...
Support Center